PMA device
Contak CD
Boston Scientific Corp · Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK, Class III) · First FDA decision May 20, 2002, newest Mar 4, 2022Heart failureVentricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
1
Naming "Contak CD"
MAUDE reports
1
Brand "Contak CD", since 2015
PubMed studies
20
Mentioning "Contak CD"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Contak CD
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- Contak CD, Easytrak, Livian, Cognis and Acuity Spirial Automatic Implantable Cardiac Resynchronization Therapy DefibrillPMA supplement
P010012-S550 · Decided Mar 4, 2022 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
- CONTAK CD (MODEL 1823), CONTAK CD 2 (MODELS H115 AND H119), RENEWAL (MODEL H135), RENEWAL 3 (MODELS H170, H175, H177, APMA supplement
P010012-S026 · Decided Sep 14, 2004 · 169 days after receipt · Panel Track
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
P010012-S017 · Decided Feb 6, 2004 · 85 days after receipt · Normal 180 Day Track
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
3 more FDA decisions with a free account
Older decisions: P010012-S001
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy System (WiSE CRT)National analysisReview closedCAG-00471NUpdated Nov 18, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Contak CD", any status and sponsor, newest update first.
- Safety and Effectiveness of Cardiac Resynchronization Therapy With DefibrillationPivotal-lookingCompleted
Boston Scientific CorporationPublic (BSX)
NCT00387803 · 581 participants · Start Feb 1998
Device: Cardiac Resynchronization Therapy with Defibrillation · For: Heart Failure, Congestive; Ventricular Fibrillation; Tachycardia, Ventricular
Sites: Saint Paul, Minnesota
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Contak CD", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code NIK
127,080 reports: 63,286 malfunction, 61,191 injury, 2,565 death
Newest reports for this brand
- CONTAK CDInjury
2124215-2017-20158 · Received Jan 15, 2018 · Event dated Apr 25, 2003
Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
Device problem as coded: Over-Sensing; Inappropriate/Inadequate Shock/Stimulation
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1671-2022 · Started Jul 7, 2022
Reason given: There is potential for unanticipated software anomalies to occur when using the Model 2868 Application loaded on the 3120 ZOOM LATITUTDE programmer when communicating with certain Boston Scientific transvenous defibrillators.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
Z-0079-2018 · Started Oct 4, 2017
Reason given: The devices have an incorrect firmware configuration.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
- MOMENTUM X4 CRT-D, Model G138, Sterile.Terminated
Z-0080-2018 · Started Oct 4, 2017
Reason given: The devices have an incorrect firmware configuration.
Cause as FDA categorized it: Under Investigation by firm · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
16 more recall records with a free account
Published research
The most relevant PubMed records for "Contak CD"[tiab]. The summary above synthesizes these.
- Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.
Santangeli P, Di Biase L, Pelargonio G, et al. · J Interv Card Electrophysiol · 2011Comparative Study, Meta-Analysis
- Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC.
Salukhe TV, Dimopoulos K, Francis D · Int J Cardiol · 2004Editorial, Meta-Analysis
- Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy.
Marcus GM, Rose E, Viloria EM, et al. · J Am Coll Cardiol · 2005
- Transvenous left ventricular lead implantation with the EASYTRAK lead system: the European experience.
Pürerfellner H, Nesser HJ, Winter S, et al. · Am J Cardiol · 2000
- Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy.
Sohaib SM, Chen Z, Whinnett ZI, et al. · Eur J Heart Fail · 2013Meta-Analysis, Research Support, Non-U.S. Gov't
- Cardiac resynchronization therapy for treatment of chronic heart failure.
Cohen TJ, Klein J · J Invasive Cardiol · 2002Review
- Long-term retention of cardiac resynchronization therapy.
Knight BP, Desai A, Coman J, et al. · J Am Coll Cardiol · 2004Clinical Trial, Comparative Study
- Which patients with congestive heart failure may benefit from biventricular pacing?
Galizio NO, Pesce R, Valero E, et al. · Pacing Clin Electrophysiol · 2003
- The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies.
McSwain RL, Schwartz RA, DeLurgio DB, et al. · J Cardiovasc Electrophysiol · 2005Research Support, Non-U.S. Gov't
- [Cardioresynchronizing therapy in treatment of cardiac insufficiency].
Popov SV, Antonchenko IV, Savenkova GM, et al. · Vestn Ross Akad Med Nauk · 2007English Abstract, Review
- Performance of a new steroid-eluting coronary sinus lead designed for left ventricular pacing.
Achtelik M, Bocchiardo M, Trappe HJ, et al. · Pacing Clin Electrophysiol · 2000Clinical Trial, Multicenter Study
- Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy.
Schuger C, Ellenbogen KA, Faddis M, et al. · J Cardiovasc Electrophysiol · 2006Multicenter Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code NIK.
- Amplia MRI CRT-DMedtronic Cardiac Rhythm Disease Management · PMA 2022
- Promote/+/RF/QAbbott Medical · PMA 2026
- Frontier/Frontier Ii/Anthem Family of Crt-PsAbbott Medical · PMA 2016
- Microny Family of PacemakersAbbott Medical · PMA 2016
- Sensolog/Dialog/Regency Family of PacemakersSt. Jude Medical, Inc. · PMA 2016
- Contak Cd,easytrakBoston Scientific Corp · PMA 2026
- Quadra Assura/Unify Assura Family of Crt-DsAbbott Medical · PMA 2016
- Concerto/Insync Sentry/Insync Maximo Implantable Cardiovascular Defibrillators with Cardiac ResynchicnizationMedtronic Cardiac Rhythm Disease Management · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.